Here is a new option for the management of anterior segment disease.
Read about the latest research papers, news and reviews.
Although new treatments for inherited retinal dystrophy are in development, they are not yet available to offer to patients.
Pharmacologic penalisation of the sound eye is an alternative treatment to patching.
A patient needing services for one issue has an unrelated condition diagnosed.
Prompt diagnosis can mean the difference between beneficial treatment and vision loss.
Anti-VEGF injections are superior to laser and can result in visual gain.
An illustrated diagnostic guide aids differential diagnosis.
OCT-A clearly demonstrates the impact of anti-VEGF treatment.
A comprehensive ophthalmic assessment of patients with diabetes is essential.
Prevention and aggressive management are required to combat diabetes.
Half of Graves’ disease patients experience symptoms of ophthalmopathy.
RVO has a complex patholophysiology with multiple contributing factors.
This issue of Pharma is supported by Bayer Australia Ltd.